The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms

Diagnostic Microbiology and Infectious Disease

Volumn 72, Issue 4, 2012, Pages 297-302

  Van der Bij, Akke K ^a,b   Peirano, Gisele ^c,d   Pitondo Silva, André ^e   Pitout, Johann D D ^c,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c CALGARY LABORATORY SERVICES   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CTX M lactamases; E. coli; Sequence types; Virulence factors

Indexed keywords

AEROBACTIN; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE CTX M; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SIDEROPHORE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CANADA; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC CODE; HRA GENE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NETHERLANDS; NONHUMAN; PATHOGENICITY; PHYLOGENY; PRIORITY JOURNAL; SAT GENE;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CANADA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; PHYLOGENY; RESPIRATORY TRACT INFECTIONS; URINARY TRACT INFECTIONS; VIRULENCE; VIRULENCE FACTORS;

EID: 84858336880     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.12.011     Document Type: Article

References (33)

1. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 2000, 66:4555-4558.
2. Clermont O., Dhanji H., Upton M., Gibreel T., Fox A., Boyd D., Mulvey M.R., Nordmann P., Ruppé E., Sarthou J.L., Frank T., Vimont S., Arlet G., Branger C., Woodford N., Denamur E. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 2009, 64:274-277.
3. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: 19th and 21st information supplements (M100-S19) 2009, CLSI, Wayne, PA.
4. Coque T.M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., Baquero F., Canton R., Nordmann P. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 2008, 14:195-200.
5. Cortes P., Blanc V., Mora A., Dahbi G., Blanco J.E., Blanco M., López C., Andreu A., Navarro F., Alonso M.P., Bou G., Blanco J., Llagostera M. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl. Environ. Microbiol. 2010, 76:2799-2805.
6. Dobrindt U. (Patho-)Genomics of Escherichia coli. Int. J. Med. Microbiol. 2005, 295:357-371.
7. Herzer P.J., Inouye S., Inouye M., Whittam T.S. Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J. Bacteriol. 1990, 172:6175-6181.
8. Hornsey M., Phee L., Wareham D.W. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agents Chemother 2011, 55:5952-5954.
9. Johnson J.R., Johnston B., Clabots C., Kuskowski M.A., Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 2010, 51:286-294.
10. Johnson J.R., Menard M., Johnston B., Kuskowski M.A., Nichol K., Zhanel G.G. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 2009, 53:2733-2739.
11. Jones G.L., Warren R.E., Skidmore S.J., Davies V.A., Gibreel T., Upton M. Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 2008, 62:1245-1251.
12. Kim J., Bae I.K., Jeong S.H., Chang C.L., Lee C.H., Lee K. Characterization of IncF plasmids carrying the blaCTX-M-14 gene in clinical isolates of Escherichia coli from Korea. J. Antimicrob. Chemother. 2011, 66:1263-1268.
13. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., Fishman N.O. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 2001, 32:1162-1171.
14. Mihaila L., Wyplosz B., Clermont O., Garry L., Hipeaux M.C., Vittecoq D., Dussaix E., Denamur E., Branger C. Probable intrafamily transmission of a highly virulent CTX-M-3-producing Escherichia coli belonging to the emerging phylogenetic subgroup D2 O102-ST405 clone. J. Antimicrob. Chemother. 2010, 65:1537-1539.
15. Mshana S.E., Imirzalioglu C., Hain T., Domann E., Lyamuya E.F., Chakraborty T. Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania. Clin. Microbiol. Infect. 2011, 17:1279-1282.
16. Mushtaq S., Irfan S., Sarma J.B., Doumith M., Pike R., Pitout J., Livermore D.M., Woodford N. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J. Antimicrob. Chemother. 2011, 66:2002-2005.
17. Park C.H., Robicsek A., Jacoby G.A., Sahm D., Hooper D.C. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 2006, 50:3953-3955.
18. Peirano G., Pitout J.D. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 2010, 35:316-321.
19. Peirano G., Richardson D., Nigrin J., McGeer A., Loo V., Toye B., Alfa M., Pienaar C., Kibsey P., Pitout J.D. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada. Antimicrob. Agents Chemother. 2010, 54:1327-1330.
20. Pitout J.D., Gregson D.B., Campbell L., Laupland K.B. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob. Agents Chemother. 2009, 53:2846-2851.
21. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 2008, 8:159-166.
22. Poirel L., Bernabeu S., Fortineau N., Podglajen I., Lawrence C., Nordmann P. Emergence of OXA-48-producing Escherichia coli clone ST38 in France. Antimicrob. Agents Chemother. 2011, 55:4937-4938.
23. Robicsek A., Strahilevitz J., Sahm D.F., Jacoby G.A., Hooper D.C. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 2006, 50:2872-2874.
24. Russo T.A., Johnson J.R. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003, 5:449-456.
25. Smet A., Martel A., Persoons D., Dewulf J., Heyndrickx M., Claeys G., Lontie M., Van Meensel B., Herman L., Haesebrouck F., Butaye P. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb. Drug Resist. 2010, 16:129-134.
26. Sullivan C.B., Diggle M.A., Clarke S.C. Multilocus sequence typing: data analysis in clinical microbiology and public health. Mol. Biotechnol. 2005, 29:245-254.
27. Suzuki S., Shibata N., Yamane K., Wachino J., Ito K., Arakawa Y. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. J. Antimicrob. Chemother. 2009, 63:72-79.
28. Tumbarello M., Sanguinetti M., Montuori E., Trecarichi E.M., Posteraro B., Fiori B., Citton R., D'Inzeo T., Fadda G., Cauda R., Spanu T. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob. Agents Chemother. 2007, 51:1987-1994.
29. van der Bij A.K., Peirano G., Goessens W.H., van der Vorm E.R., van Westreenen M., Pitout J.D. Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, Netherlands. Antimicrob. Agents Chemother. 2011, 55:3576-3578.
30. Wiles T.J., Kulesus R.R., Mulvey M.A. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 2008, 85:11-19.
31. Yamamoto T., Takano T., Iwao Y., Hishinuma A. Emergence of NDM-1-positive capsulated Escherichia coli with high resistance to serum killing in Japan. J. Infect. Chemother. 2011, 17:435-439.
32. Yamane K., Wachino J., Suzuki S., Arakawa Y. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob. Agents Chemother. 2008, 52:1564-1566.
33. Zong Z., Yu R. Escherichia coli carrying the blaCTX-M-15 gene of ST648. J. Med. Microbiol. 2010, 59:1536-1537.